Intestinal histomorphological and molecular alterations in patients with Parkinson's disease.

Gabriele BelliniLaura BenvenutiChiara IppolitoDaniela FrosiniCristina SegnaniFrancesco RetturaAndrea PancettiLorenzo BertaniVanessa D'AntongiovanniGiovanni PalermoEleonora Del PreteLuca AntonioliVincenzo NardiniRiccardo MorgantiCarolina PellegriniNunzia BernardiniRoberto CeravoloMatteo FornaiMassimo Bellini

Published in: European journal of neurology (2022)

Parkinson's disease patients are characterized by enteric inflammation and increased intestinal epithelial barrier permeability, as well as colonic mucosal barrier remodelling, associated with changes in gut microbiota composition.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
oxidative stress
peritoneal dialysis
ulcerative colitis
endothelial cells
patient reported outcomes
single molecule
patient reported